- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07597044
Evaluation of Sensitivity and Color Change of Different Protocols of In-office Dental Bleaching
Panoramica dello studio
Stato
Condizioni
Intervento / Trattamento
Descrizione dettagliata
Two weeks before the bleaching procedures, selected volunteers from the city of Nova Friburgo, (Rio de Janeiro, Brazil) received a dental screening and a dental prophylaxis with pumice and water in a rubber cup and signed an informed consent form.
This was a randomized, single-blind (evaluators), parallel and equivalence trial with an equal allocation rate between groups.
A total of 71 participants were examined in a dental chair to check if they met the inclusion and exclusion criteria. A total of 40 participants were included in this study. The participants were randomly divided in the 40-minutes or 2x20-minutes groups.
During the in-office sessions, participants had the gingival tissue isolated of the teeth using a light-cured resin dam (Opal Dam, Ultradent Products International, Salt Lake, Utah, USA). After that, the 40% hydrogen peroxide gel (Opalescence Boost, Ultradent) was applied in one 40-min application according to the manufacturer's directions in all upper and lower incisors, canines and premolars, or was applied in the same teeth, but during 2 x 20-min applications, with no interval between them. After 20 minutes, the bleaching gel was removed with water spray before the second 20 minutes application. After 7 days this procedure was repeated using the same protocols.
Color evaluation was performed before and 30 days after the end of the bleaching treatment using a subjective (value oriented shade guide Vita Lumin, Vita Zahnfabrik, Bad Sackingen, Germany) and an objective method (Easyshade spectrophotometer, Vident, Brea, CA, USA). Color evaluation was done in a room under artificial lightning conditions without interference from outside light.
For the subjective examination, the shadeguide's 16 tabs were arranged from highest (B1) to lowest (C4) value. Changes in the scale were treated as representing a continuous and approximately linear ranking. Color was measured in the middle third of the facial surface of the right upper canine at baseline and 30 days after bleaching to calculate the variations in color towards the lighter end of the scale (Delta Shade Guide Units - DSGU).
One calibrated operator measured the color in all participants using the Vita Easyshade spectrophotomer (Easyshade, Vident, Brea, CA, USA) before and 30 days after the bleaching therapy. The L*, a* and b* parameters were recorded. L* represents the value from 0 (black) to 100 (white) and a* and b* represent the shade, where a* is the measurement along the red-green axis and b* is the measurement along the yellow-blue axis. Color change was calculated between the two assessment periods (DE) using the formula: DE = [(DL*)2 + (Da*)2 + (Db*)2]1/2.
The patients recorded their perception of TS during the first and second bleaching sessions using the visual analogue scale VAS. This scale employs a 10-cm horizontal line with words "no pain" at one end and "worst pain" at the opposite end. Participants recorded whether they experienced TS during the treatment up to 1 h after the bleaching, from 1 h to 24 hand from 24h to 48 h after bleaching. In the 30-day recall, patients were also asked if they experienced pain during this 30-day period. As two bleaching sessions were performed, the VAS score obtained in both bleaching sessions was considered for statistical purposes. These values
Tipo di studio
Iscrizione (Effettivo)
Fase
- Non applicabile
Contatti e Sedi
Luoghi di studio
-
-
Rio de Janeiro
-
Nova Friburgo, Rio de Janeiro, Brasile, 28625-650
- Universidade Federal Fluminense - School of Dentistry
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Descrizione
Inclusion Criteria:
The selected volunteers should:
- Present Good general state of health
- Be at least 18 years of age
- Have an acceptable oral hygiene
- Present the upper and lower arches without absence of teeth of first premolar right to the left first premolar.
- Have anterior teeth with any kind of restoration.
- Be No smoker
- Have the upper right canine with color 2M2 or darker
Exclusion Criteria:
The selected volunteers should not:
- Have medical history of diseases that can affect the results of the study
- Have made use of cigarettes in the last 30 days
- Have some important pathology in the oral cavity
- Be pregnant
- Be breastfeeding
- Have moderate advanced periodontal disease;
- Have consumed drugs, alcool or any medication that can cover the results, as other types of anti-inflammatories or painkillers;
- Have used products indicated for dental sensitivity, as desensitizing toothpaste or similar product
- Present gingival recession
- Present exacerbated hypersensitivity history
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Separare
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Comparatore attivo: Bleaching 40 minutes
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 40 minutes according to manufacturer's instructions.
|
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 40 minutes according to manufacturer's instructions.
|
|
Sperimentale: Bleaching 2x20 minutes
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 20 minutes, will be removed (with water) and a new application of 20 minutes will be made.
|
Patients will have their teeth bleached in-office using 40% Hydrogen Peroxide (commercial available product - Opalescence Boost, Ultradent Products International) in two sections with 7 days of interval between sections.
In each section, the product will be used during 20 minutes, will be removed with water, and another application of 20 minutes will be made.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Tooth sensitivity
Lasso di tempo: 1 hour after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
1 hour after dental bleaching session
|
|
Tooth sensitivity
Lasso di tempo: 24 hours after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
24 hours after dental bleaching session
|
|
Tooth sensitivity
Lasso di tempo: 48 hours after dental bleaching session
|
Visual Analogic Scale (0-100) for Tooth Sensitivity.
In this case, zero means no sensitivity (a better outcome and 100 means higher sensitivity (worse outcome).
|
48 hours after dental bleaching session
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Color change with scale
Lasso di tempo: 30 days after dental bleaching session
|
Objective color evaluation comparing tooth color against a comercial color scale from A1 to D4
|
30 days after dental bleaching session
|
|
Color change with spectrophotometer
Lasso di tempo: 30 days after dental bleaching session
|
Objective color evaluation using a spectrophotometer
|
30 days after dental bleaching session
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: MARCOS O BARCELEIRO, PhD, Full Professor
Pubblicazioni e link utili
Pubblicazioni generali
- Carey CM. Tooth whitening: what we now know. J Evid Based Dent Pract. 2014 Jun;14 Suppl:70-6. doi: 10.1016/j.jebdp.2014.02.006. Epub 2014 Feb 13.
- de Paula EA, Loguercio AD, Fernandes D, Kossatz S, Reis A. Perioperative use of an anti-inflammatory drug on tooth sensitivity caused by in-office bleaching: a randomized, triple-blind clinical trial. Clin Oral Investig. 2013 Dec;17(9):2091-7. doi: 10.1007/s00784-013-0918-2. Epub 2013 Jan 31.
- de Paula EA, Nava JA, Rosso C, Benazzi CM, Fernandes KT, Kossatz S, Loguercio AD, Reis A. In-office bleaching with a two- and seven-day intervals between clinical sessions: A randomized clinical trial on tooth sensitivity. J Dent. 2015 Apr;43(4):424-9. doi: 10.1016/j.jdent.2014.09.009. Epub 2014 Sep 23.
- da Costa Poubel LA, de Gouvea CVD, Calazans FS, Dip EC, Alves WV, Marins SS, Barcelos R, Barceleiro MO. Pre-operative use of dexamethasone does not reduce incidence or intensity of bleaching-induced tooth sensitivity. A triple-blind, parallel-design, randomized clinical trial. Clin Oral Investig. 2019 Jan;23(1):435-444. doi: 10.1007/s00784-018-2452-8. Epub 2018 Apr 25.
- de Mendonca RP, Baliza JR, Burey A, Cavalcante LM, Loguercio AD, Calazans FS, Barceleiro MO. In vitro analysis of the pH stability of dental bleaching gels during in-office procedures. J Clin Exp Dent. 2021 Jan 1;13(1):e22-e29. doi: 10.4317/jced.57367. eCollection 2021 Jan.
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- UFFBleachingProtocols
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Sensibilità dei denti
-
Hereditary Neuropathy FoundationReclutamentoMalattia di Charcot-Marie-Tooth | Malattia di Charcot-Marie-Tooth, tipo IA | Malattia di Charcot-Marie-Tooth di tipo 2A | Charcot-Marie-Tooth | Malattia di Charcot-Marie-Tooth, tipo IB | Malattia di Charcot-Marie-Tooth di tipo 2 | Malattia di Charcot-Marie-Tooth, tipo 2C | Malattia di Charcot-Marie-Tooth... e altre condizioniStati Uniti
-
n-Lorem FoundationThe University of Texas Health Science Center, HoustonIscrizione su invitoMalattia di Charcot-Marie-Tooth di tipo 2DStati Uniti
-
Elpida Therapeutics SPCNon ancora reclutamentoMalattia di Charcot-Marie-Tooth tipo 4J
-
University Medical Center GoettingenReclutamentoMalattia di Charcot Marie Tooth | CMT (malattia di Charcot Marie Tooth) | CMT | Malattia di Charcot Marie Tooth (CMT)Germania
-
University College, LondonUniversity of IowaSconosciutoMalattia di Charcot-Marie-Tooth, tipo IA | Malattia di Charcot-Marie-Tooth di tipo 2A | Malattia di Charcot-Marie-Tooth, tipo IB | Malattia di Charcot-Marie-Tooth, tipo XRegno Unito
-
University Hospital, Clermont-FerrandCompletatoNeuropatia di Charcot-Marie-Tooth di tipo 1AFrancia
-
Applied Therapeutics, Inc.RitiratoMalattia Charcot-Marie-Tooth con deficit di sorbitolo deidrogenasi (CMT-Sord)Stati Uniti, Francia, Germania, Spagna, Turchia (Türkiye), Australia, Italia
-
University Hospital, Clermont-FerrandCompletatoNeuropatia di Charcot-Marie-Tooth di tipo 1AFrancia
-
University Medical Center GoettingenReclutamentoCMT - Malattia di Charcot-Marie-Tooth | CMT1A | CMT (malattia di Charcot Marie Tooth)Germania
-
Tasly GeneNet Pharmaceuticals Co., LtdCompletatoCharcot-Marie-Tooth Tipo 1ACina